tiprankstipranks
Trending News
More News >
Keros Therapeutics, Inc. (KROS)
:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Ownership - Who Owns Keros Therapeutics?

Compare
348 Followers

Keros Therapeutics (KROS) Ownership Overview

40.88%12.48%0.25%12.75%33.64%
40.88% Insiders
0.25% Other Institutional Investors
12.75% ETFs
33.64% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 25.47% of the company’s stock is owned by Institutional Investors, 40.88% is owned by Insiders, and 33.64% is owned by Public Companies and Individual Investors.
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 12.73% of the company’s stock is owned by Institutional Investors, 40.88% is owned by Insiders, and 12.75% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 24, 2025
xxxxxxxxxxxxx
$118000
Apr 11, 2025
xxxxxxxxxxxxx
$9462056

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$20490821

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,134,595Insider12.64%74,348,936
4,637,319Insider11.42%67,148,379
4,637,319Insider11.42%67,148,379
1,724,330Institution4.25%24,968,298
1,593,944Institution3.92%23,080,309
1,534,893Institution3.78%22,225,251
1,451,212Institution3.57%21,013,550
1,023,984Insider2.52%14,827,288
934,054Institution2.30%13,525,102
768,803Institution1.89%11,132,267

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,593,944Institution3.92%23,080,309
934,054Institution2.30%13,525,102
368,541Institution0.91%5,336,474
363,205Institution0.89%5,259,208
350,378Institution0.86%5,073,473
243,078Institution0.60%3,519,769
198,274Institution0.49%2,871,008
115,812Institution0.29%1,676,958
111,700Institution0.28%1,617,416
102,137Institution0.25%1,478,944

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,068,641Institution2.63%15,302,939
819,684Institution2.02%11,869,024
688,312Institution1.69%9,925,459
381,250Institution0.94%5,459,500
353,384Institution0.87%5,117,000
300,201Institution0.74%4,346,910
208,089Institution0.51%3,013,129
167,467Institution0.41%2,414,874
161,376Institution0.40%2,310,904
156,111Institution0.38%2,260,487

FAQ

Who Owns Keros Therapeutics, Inc. (KROS)?
According to the latest TipRanks data, approximately 0.25% of the company's stock is held by institutional investors, 40.88% is held by insiders, and 33.64% is held by retail investors.
    What percentage of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.25% of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors.
      What percentage of Keros Therapeutics, Inc. (KROS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.64% of Keros Therapeutics, Inc. (KROS) stock is held by retail investors.
        Who owns the most shares of Keros Therapeutics, Inc. (KROS)?
        ADAR1 Capital Management, LLC owns the most shares of Keros Therapeutics, Inc. (KROS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis